Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Published:2011-07 Issue:1 Volume:38 Page:65-69
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Pfaller Michael A.,Messer Shawn A.,Moet Gary J.,Jones Ronald N.,Castanheira Mariana

Funder

Pfizer

Astellas

Achaogen

Anacor

API

Arpida

ARYx

AstraZeneca

Avexa

Bayer

bioMérieux

Becton Dickinson

Cadence

Cempra

Cerexa

Cornerstone Biopharma

Cosmo Technologies

Cubist

Elan

Enanta

GlaxoSmithKline

Johnson & Johnson

LegoChem Biosciences Inc.

Meiji Seika Kaisha

Microphage Inc.

Migenix

Mpex

Nabriva

Novexel

Novartis

Optimer

Ordway

Paratek

PPD Therapeutics

Premier Research Group

Protez

Shionogi USA

The Medicines Co.

Theravance

TREK Diagnostics

Vertex Pharmaceuticals

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference52 articles.

1. Invasive Candida species infection: the importance of adequate empirical antifungal therapy;Armstrong-James;J Antimicrob Chemother,2007

2. Timely selection of adequate antifungal therapy for candidemia in the critically ill: don’t let the yeast rise!;Corona;Crit Care Med,2008

3. Global trends in candidemia: review of reports from 1995–2005;Morgan;Curr Infect Dis Rep,2005

4. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections;Parkins;J Antimicrob Chemother,2007

5. International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidiasis;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Potential antifungal applications of heterometallic silica nanohybrids: A synergistic activity;Biomaterials Advances;2024-09

3. Evaluation of Clinical and Epidemiologic Characteristics, Risk Factors and Treatment Regimens of Invasive Candida Infections in Children;OSMANGAZİ JOURNAL OF MEDICINE;2024-07-16

4. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis;Expert Review of Anti-infective Therapy;2024-06-02

5. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens;Medical Mycology;2024-06